197 related articles for article (PubMed ID: 33565130)
1. Prognostic impact and risk factors of cancer-associated thrombosis events in stage-IV cancer patients treated with immune checkpoint inhibitors.
Kewan T; Ko T; Flores M; Sallam Y; Haddad A; Daw H
Eur J Haematol; 2021 May; 106(5):682-688. PubMed ID: 33565130
[TBL] [Abstract][Full Text] [Related]
2. Incidence of venous thromboembolism and discriminating capacity of Khorana score in lung cancer patients treated with immune checkpoint inhibitors.
Alma S; Eloi D; Léa V; Julie C; Valérie M; Pierre G; Hilgers W; Philippe G; Christine Z; Philippe D
J Thromb Thrombolysis; 2022 Aug; 54(2):287-294. PubMed ID: 35396660
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for cancer-associated thrombosis in patients undergoing treatment with immune checkpoint inhibitors.
Ando Y; Hayashi T; Sugimoto R; Nishibe S; Ito K; Kawada K; Ikeda Y; Yamada S; Imaizumi K
Invest New Drugs; 2020 Aug; 38(4):1200-1206. PubMed ID: 31823160
[TBL] [Abstract][Full Text] [Related]
4. The Khorana score and venous and arterial thrombosis in patients with cancer treated with immune checkpoint inhibitors: A Danish cohort study.
Overvad TF; Skjøth F; Piazza G; Noble S; Ording AG; Larsen TB; Nielsen PB
J Thromb Haemost; 2022 Dec; 20(12):2921-2929. PubMed ID: 36112135
[TBL] [Abstract][Full Text] [Related]
5. Incidence, risk factors, and outcomes of venous and arterial thromboembolism in immune checkpoint inhibitor therapy.
Moik F; Chan WE; Wiedemann S; Hoeller C; Tuchmann F; Aretin MB; Fuereder T; Zöchbauer-Müller S; Preusser M; Pabinger I; Ay C
Blood; 2021 Mar; 137(12):1669-1678. PubMed ID: 33067632
[TBL] [Abstract][Full Text] [Related]
6. The value of performance status in predicting venous thromboembolism in lung cancer patients treated with immune checkpoint inhibitors.
Zhang J; Yang L; Tian H; Xu R; Liu D
Eur J Oncol Nurs; 2024 Apr; 69():102527. PubMed ID: 38377652
[TBL] [Abstract][Full Text] [Related]
7. Interaction between NSCLC Cells, CD8
Freitas-Dias C; Gonçalves F; Martins F; Lemos I; Gonçalves LG; Serpa J
Cells; 2024 Feb; 13(4):. PubMed ID: 38391918
[TBL] [Abstract][Full Text] [Related]
8. Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors.
Zhong L; Wu Q; Chen F; Liu J; Xie X
Cancer Immunol Immunother; 2021 Sep; 70(9):2559-2576. PubMed ID: 33576872
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the effect of immune checkpoint inhibitors on venous thromboembolism in non-small cell lung cancer patients.
He X; Wei SN; Qin WW; Geng N; Li B; Song S; Wang P
Expert Rev Hematol; 2023; 16(12):1135-1142. PubMed ID: 37883026
[TBL] [Abstract][Full Text] [Related]
10. Immune-related Adverse Events and Survival in Solid Tumors Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Petrelli F; Grizzi G; Ghidini M; Ghidini A; Ratti M; Panni S; Cabiddu M; Ghilardi M; Borgonovo K; Parati MC; Tomasello G; Barni S; Berruti A; Brighenti M
J Immunother; 2020 Jan; 43(1):1-7. PubMed ID: 31574022
[TBL] [Abstract][Full Text] [Related]
11. Immune Checkpoint Inhibitors-Associated Thrombosis: Incidence, Risk Factors and Management.
Wang TF; Carrier M
Curr Oncol; 2023 Mar; 30(3):3032-3046. PubMed ID: 36975443
[TBL] [Abstract][Full Text] [Related]
12. Immune-related adverse events and immune checkpoint inhibitor tolerance on rechallenge in patients with irAEs: a single-center experience.
Bhatlapenumarthi V; Patwari A; Harb AJ
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2789-2800. PubMed ID: 33774736
[TBL] [Abstract][Full Text] [Related]
13. Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities.
Xu Y; Fu Y; Zhu B; Wang J; Zhang B
Front Immunol; 2020; 11():2023. PubMed ID: 33123120
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study.
Mandala M; Lorigan P; De Luca M; Bianchetti A; Merelli B; Bettini AC; Bonomi L; Nahm S; Vitale MG; Negrini G; Di Croce A; Ascierto PA; Rulli E; Tondini CA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33593827
[TBL] [Abstract][Full Text] [Related]
15. A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis Study.
Gerotziafas GT; Taher A; Abdel-Razeq H; AboElnazar E; Spyropoulos AC; El Shemmari S; Larsen AK; Elalamy I;
Oncologist; 2017 Oct; 22(10):1222-1231. PubMed ID: 28550032
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group.
Cánovas MS; Garay DF; Moran LO; Pérez JR; Rubio CMG; de Mena ML; Portero BO; Castro JB; Lage Y; Lavin DC; Blanco ABR; de Soignie AMMF; Perejón JZB; Colomo LJ; Boluda NB; Moreno JB; Verduguez TQ; Garrido CR; Huertas RM; Puig CFI; Martín AJM
Clin Transl Oncol; 2022 Oct; 24(10):2010-2020. PubMed ID: 35668339
[TBL] [Abstract][Full Text] [Related]
17. Validation of the American Joint Committee on Cancer Eighth Edition Staging of Patients With Metastatic Cutaneous Melanoma Treated With Immune Checkpoint Inhibitors.
Waninger JJ; Ma VT; Journey S; Skvarce J; Chopra Z; Tezel A; Bryant AK; Mayo C; Sun Y; Sankar K; Ramnath N; Lao C; Sussman JB; Fecher L; Alva A; Green MD
JAMA Netw Open; 2021 Mar; 4(3):e210980. PubMed ID: 33687443
[TBL] [Abstract][Full Text] [Related]
18. Venous and arterial thromboembolic events with immune checkpoint inhibitors: A systematic review.
Solinas C; Saba L; Sganzerla P; Petrelli F
Thromb Res; 2020 Dec; 196():444-453. PubMed ID: 33065409
[TBL] [Abstract][Full Text] [Related]
19. Assessing the risk of thromboembolism in cancer patients receiving immunotherapy.
Goel A; Khorana A; Kartika T; Gowda S; Tao DL; Thawani R; Shatzel JJ
Eur J Haematol; 2022 Apr; 108(4):271-277. PubMed ID: 34905252
[TBL] [Abstract][Full Text] [Related]
20. The impact of antibiotics on efficacy of immune checkpoint inhibitors in malignancies: A study based on 44 cohorts.
Wu Q; Liu J; Wu S; Xie X
Int Immunopharmacol; 2021 Mar; 92():107303. PubMed ID: 33465728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
